The global pharmaceutical gelatin market size is estimated to grow at a CAGR of 6.2% from 2021 to 2026 and is forecasted to be worth USD 1.32 billion by 2026.
Pharmaceutical gelatin is a translucent, brittle, and water-soluble element with a heavy molecular weight and protein-rich source. The gelatin is derived from collagen present in the animals such as fish, bovines, and sheep and is used in the food and beverages industry for gelling, streaming, and foaming properties. This is available in two different forms, known as powder and sheets, and it has unique and versatile characteristics across pharmaceutical applications. Most of the gelatin is derived from animal tissues as it has a huge amount of collagen, and there are different procedures to extract the gelatin. The procedures involved are salting out, alkaline, acid, and enzyme methods.
The pharmaceutical gelatins are extremely dynamic and highly utilized in few biomedical and medical applications. The gelatins mostly come from natural sources as they have a huge demand for usage in several pharma applications like soft gels and hard gels. The gelatin coating is efficient for advancing the medicine's shelf-life by safeguarding it against various environmental changes. The gelatin coating on the tablets, soft gels, and hard gels makes easy swallowing of medicines and doesn't let the medicine's odor off.
The global pharmaceutical gelatin market is primarily driven by the factors such as growing demand for functional and convenience food & beverage products, increasing applications in the pharmaceutical industries, and a rise in the need for clean label products. Also, the Unique and functional characteristics of gelatin in pharmaceutical applications, the increase in chronic disease incidence with a growing population worldwide create market growth.
Also, gelatin production in capsule formation in the emerging market influences the global pharmaceutical gelatine market growth. Moreover, rising flexibility, strength, and consistency of various products, safety stability, and improved efficacy in hard capsules these factors are expected to expand the market growth. Pharmaceutical gelatin offers many technological advantages over non-gelatin excipients like HMPC for hard capsules, and modified starch for softgels is further anticipated to improve the market growth.
Increasement in the popularity of veganism is the primary restraint in the pharmaceutical gelatin market. Nowadays, veganism is trending in the market. This trend is rising globally, with the manufacturers offering non-gelatin capsules or vegetarian capsules from pure plant materials that meet the consumer's demands. Increasing the demand for plant-based pharmaceuticals products and changes in the product portfolios is expected as the restraint of the pharmaceutical gelatin in the forecast period.
The major challenge is the rise in the prices and acquisition of the availability of raw materials. The slaughterhouses and meat industries extract most of the gelatin. In most governments, there are strict regulations in handling the raw material by ensuring the prevention of the passage of the diseases caused by the animal-borne, which is further affecting the supply of export or import in any region at the time. These are the main factors that are challenging the pharmaceutical gelatin market's growth over the forecast period.
Impact of COVID-19 on the global pharmaceutical gelatin market:
Across the globe, there is a rise in the prevalence of the COVID-19 is also driving the demand of the pharmaceutical industry. However, there are issues in the transportation and logistics in the various regions due to days of the lockdown and quarantine, resulting in difficulties in the procurement of raw materials for the pharmaceutical gelatin.
During the first half of 2020, the pandemic and winding down of global science activities have affected many industry participants' operations and financial results in the gelatin market. Due to the sudden outbreak, governments had imposed nationwide lockdown and a ban on travel and various transportation modes to control the virus's spread. The gelatin capsules are made using raw material; due to the ban on transportation, the supply chain had been stopped. However, the second half is expected to impact the growth positively due to the postponed activities were resumed. Manufacturers in the industry focus on producing gelatin capsules, and the research activities have been boosted since the unlock of lockdown. The market is expected to increase its growth by 2021.
Market Size Available
2020 to 2026
2021 to 2026
By Function, Source, Application, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
This research report on the global pharmaceutical gelatin market has been segmented and sub-segmented based on the function, source, application, and region.
Pharmaceutical Gelatin Market – By Function:
Based on function, thickening agents register a significant growth rate as it has the rise of the scope due to applications in the elixis, syrups, and other liquid forms. The gelatin's utility in the lotions and antibiotics creams as the thickening agent is also a driver for the pharmaceutical gelatin market.
The stabilizers segment had a significant market share in 2019 with a dominant share of 246.3 kilotons. This segment's growth is driven by the rising consumption of food products such as pasta, yogurt, ice creams, jams and jellies, and salads. The Asia Pacific is anticipated to be the largest market shareholder of stablers.
Pharmaceutical Gelatin Market – By Source:
Expectedly, pigskin is accounting for the significant growth in the pharmaceutical gelatin market through the source segment. The gelatin sourced from pig skin is preferred over the other sources with a lower price. Variety of applications in the pharmaceutical industries, biomedical applications, and absorbable hemostats, lower production cost, and shorter manufacturing cycle are expected to drive this segment's market growth.
Pharmaceutical Gelatin Market – By Application:
Based on the application, soft capsules are accounting for a significant share in the pharmaceutical gelatin market. A soft gel is a soft oral dosage for the medium form of a specialized capsule. This segment growth is gained patient-friendly dosage form is formulating for rapid or slow release and a high degree of reproducibility. Patient-friendly dosage is the advantage of the soft capsules due to the capacity of formulation rapidly or slow-release. A high degree of reproducibility is the factor responsible for the growth of the pharmaceutical gelatin market through the soft capsules by this segment.
Absorbable hemostats, varieties of the pharmaceutical industry, and biomedical applications, a low production expenditure drives the pharmaceutical gelatin market.
Pharmaceutical Gelatin Market – By Region:
The Global Pharmaceutical Gelatin market was dominated by Europe closely followed by North America. Asia Pacific is expected to grow at a high CAGR. The European market is expected to be one of the largest shareholding countries in the Pharmaceutical gelatin market, with a 40% global revenue in 2019. The premium quality of collagen is being used to produce bone and tissue reconstruction patches is estimated to increase the market growth. Consumption of gelatin-based products such as food products, cosmetics, rejuvenation beverages, and pharmaceutical products is influential in the European region's gelatin market.
North America accounted for the largest market share during the current previous year and is expected to grow by coming years. The market is expansion is projected to gain by the factors such as an increase in chronic disease, a rise in geriatric population and availability of advanced healthcare facilities, and encouraging government regulations.
During the forecast period, the Asia Pacific region is ruling the pharmaceutical gelatin market by registering the highest CAGR growth rate. In this region, there are abundant availabilities of the bovine and porcine sources of the raw material, labor at a reasonable cost, and investments by the capitals. Many key players in the market are investing in investments in this region. The pharmaceutical gelatin market in the Asia Pacific is projected to increase rapidly during the forecast period. Availability of various sources of raw material in this region, low cost of labor and capital investment, and active participation of market players have been driving the market growth in this region over the years.
Middle East Africa recorded the largest market share of the pharmaceutical gelatin market during the previous year, and it is projected to expand its growth with the influential growing factors. The factors such as increasing pharmaceutical industries' applications and increasing chronic disease incidence with a growing population are projected to propel the gelatin market's growth in this region during the forecast period.
PROMISING COMPANIES IN THE MARKET:
Some of the top companies leading the global pharmaceutical gelatin market profiled in this report are Rousselot, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Tessenderlo Group, Sterling Gelatin, Roxlor LLC, Weishardt, and Gelita AG.
RECENT MARKET DEVELOPMENTS:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.4 Gelling agents
5.1.5 Y-o-Y Growth Analysis, By function
5.1.6 Market Attractiveness Analysis, By function
5.1.7 Market Share Analysis, By function
5.2.2 Pig skin
5.2.3 Bovine hides
5.2.5 Y-o-Y Growth Analysis, By source
5.2.6 Market Attractiveness Analysis, By source
5.2.7 Market Share Analysis, By source
5.3.2 Hard capsules
5.3.3 Soft capsules
5.3.4 Micro encapsulation
5.3.6 Absorbable hemostat
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By function
22.214.171.124 By source
126.96.36.199 By Application
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By function
220.127.116.11 By source
18.104.22.168 By Application
6.1.5 Market Share Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By function
188.8.131.52 By source
184.108.40.206 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Tessenderlo Group
8.3 Nitta Gelatin Inc.
8.5 Catelent Inc.
8.6 Norland Products Inc
8.7 Sterling Gelatin
8.9 Gelita AG
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures